Gastroesophageal Reflux Disease Therapeutics Market

As per the research conducted by GME, the Global Gastroesophageal Reflux Disease Therapeutics Market will grow with a CAGR value of 4.1%. During the forecasted timeframe, the gastroesophageal reflux disease market is likely to be sustained by a rise in the number of patients being treated for gastroesophageal reflux disease and long-term anti-reflux conservation therapy.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Gastroesophageal Reflux Disease Therapeutics Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-gastroesophageal-reflux-disease-therapeutics-market-3149

By Drug Type (Antacids, H2 Receptor Blockers, Proton Pump Inhibitors (PPIs) and Pro-kinetic Agents), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Key Market Insights
• Gastroesophageal reflux disease (GERD) is characterized by the reflux of stomach contents into the mouth via the oesophagus, resulting in a burning feeling behind the breastbone.
• Excessive acid production causes gastroesophageal reflux disease, which destroys the lining of the stomach and eventually leads to ulcers.
• Overconsumption of some drugs, like calcium channel blockers, nitrates, and antihistamines, can potentially induce gastroesophageal reflux disease.
• Over the previous decade, the global prevalence of acid reflux and accompanying symptoms has grown by approximately half i.e. 50%.
• The introduction of generics following the loss of monopoly of popular medications such as Nexium and Prilosec have had an impact on branded PPI sales.
• Moreover, due to improving healthcare infrastructure and the increased prevalence of GERD, the United States is likely to be the largest market.
• AstraZeneca, Addex Pharmaceuticals, Vecam, Medigus, Peer Medical, EndoGastric Solutions, Eisai Co., Ltd, Takeda Pharmaceutical Company Limited, RaQualia Pharma Inc, Reviva Pharmaceuticals Inc, Rottapharm Madaus, Torax Medical, and Mederi Therapeutics, among others are the top players in the gastroesophageal reflux disease therapeutics market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-gastroesophageal-reflux-disease-therapeutics-market-3149

Drug Type Outlook (Revenue, USD Billion, 2021-2026)
• Antacids
• H2 Receptor Blockers
• Proton Pump Inhibitors (PPIs)
• Pro-kinetic agents

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.